Genetic Techs. Ltd. v. Merial L.L.C., No. 15-1202 (Fed. Cir. 2016)
Annotate this CaseGTG’s 179 patent claims methods of analyzing sequences of genomic deoxyribonucleic acid (DNA) for decoding genetic variations. The Federal Circuit affirmed dismissal of GTG’s infringement suit, finding certain claims ineligible for patenting under 35 U.S.C. 101. The court stated that GTG’s attempts to distinguish its position on the ground that the method of the claim is useful “have no basis in case law or in logic.” The claim ineligible for claiming unpatentable subject matter, not for lack of utility; even valuable contributions can fall short of statutory patentable subject matter.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.